Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader
The COVID-19 Vaccine Studies
![](https://esot.org/wp-content/uploads/2021/02/COVID-19-Vaccine-Studies.png)